Review and interact with the multiomic data generated on the G4X Spatial Sequencer across a range of tissue types and studies.
Review the transcript, protein, and fluorescent H&E analysis of a 4×4 human tonsil section.
875 µm
875 µm
875 µm
875 µm
875 µm
875 µm
Toggle between the different cancer research projects run on the G4X Spatial Sequencer.
Toggle between the different cancer research projects run on the G4X Spatial Sequencer.
See the data to learn how high-throughput spatial sequencing with the G4X™ is enabling researchers to produce multi-modal spatial images from challenging patient samples.
Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018.
Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.
